What is the most likely diagnosis and recommended management for a patient with a total iron‑binding capacity of 339 µg/dL and a ferritin level of 8 µg/L?

Iron Deficiency Anemia - Diagnosis Confirmed

This patient has iron deficiency anemia (IDA) and requires both diagnostic evaluation to identify the underlying cause and iron replacement therapy.

Diagnostic Interpretation

Your laboratory values definitively establish iron deficiency:

• Ferritin 8 µg/L: Severely low, well below the diagnostic threshold of <45 ng/mL recommended by AGA guidelines 12. This level has 99% specificity for iron deficiency 1
• TIBC 339 µg/dL: Elevated (normal range typically 240-450 µg/dL), which is characteristic of iron deficiency as the body attempts to maximize iron absorption

The combination of low ferritin and elevated TIBC confirms absolute iron deficiency. A ferritin <15 ng/mL has 99% specificity for iron deficiency, though it only captures 59% of cases 1. Your patient's ferritin of 8 µg/L leaves no diagnostic uncertainty.

Required Diagnostic Workup

The AGA strongly recommends bidirectional endoscopy (both EGD and colonoscopy) for asymptomatic postmenopausal women and men with IDA 1. This should be performed in the same session to identify gastrointestinal sources of blood loss, particularly malignancy.

Before proceeding with endoscopy, evaluate for:

• Menstrual history (if premenopausal woman): Heavy menstrual bleeding is the most common cause in this population
• Dietary assessment: Vegan/vegetarian diet, inadequate iron intake
• Blood donation history: Frequent donation can cause iron depletion
• Celiac disease screening: All IDA patients should be assessed 2
• H. pylori testing: Can impair iron absorption 2
• Medication review: NSAIDs, anticoagulants, aspirin causing occult GI bleeding

Iron Replacement Strategy

Initiate oral iron supplementation immediately while pursuing diagnostic workup 2. The appropriate approach depends on severity and patient factors:

First-Line: Oral Iron

• Start with oral ferrous sulfate or other oral iron formulation
• Common side effects include nausea, abdominal pain, and constipation
• Continue for sufficient duration to replete iron stores (typically 3-6 months after hemoglobin normalizes)

Consider IV Iron If:

• Severe iron deficiency (as in this case with ferritin of 8)
• Intolerance to oral iron
• Malabsorption conditions (celiac disease, inflammatory bowel disease)
• Ongoing blood loss unresponsive to oral therapy
• Need for rapid repletion 2

Critical Pitfalls to Avoid

1. Do not delay endoscopy in postmenopausal women or men: Even with obvious menstrual blood loss in premenopausal women, consider GI evaluation if iron deficiency is severe or refractory to treatment
2. Do not use serum iron alone for diagnosis: It has poor diagnostic accuracy 3
3. Do not stop at hemoglobin normalization: Continue iron therapy until ferritin is adequately repleted (typically >100 µg/L) 4
4. In inflammatory conditions: Ferritin may be falsely elevated; use transferrin saturation <20% or soluble transferrin receptor as confirmatory tests 12

Treatment Targets

• Hemoglobin: 10-12 g/dL or normalization
• Ferritin: >100 µg/L (but <500-800 µg/L to avoid overload) 4
• Transferrin saturation: >20% 4

Monitor response to therapy at 4-6 weeks and adjust treatment accordingly based on hemoglobin and ferritin trends.